Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) will seek acquisitions. Dilip Shanghvi Managing Director said during the First Quarter Fiscal Year '22 Earnings Conference Call, "We will continue to focus on growing our existing business and also look at additional opportunities for us to grow. Because if you've seen Sun Pharma, I think it's a history of organic growth and bolt-on acquisitions or sometimes more strategic acquisitions. So that we can continue to grow at a significant pace, even on our very large base business".